Cancer treatment in India for Uzbek patients

Why the serious cases travel, and when they should not

Oncology has travelled from Uzbekistan to India for years, and the corridor's infrastructure reflects it: online e-Medical visas, about nineteen Tashkent–Delhi nonstops a week, Russian-language coordination on hospital international desks. None of that makes India the right answer for every diagnosis. Tashkent's own oncology services are developing, and for several common cancers a plan made at home is entirely reasonable; an independent review will sometimes conclude that travelling adds cost and strain without changing the medicine. The value of a $50 video consultation or a $150 written opinion is that this judgement arrives before money moves and before anyone resigns from work. Where one specific element — an advanced radiation course, a cellular-therapy programme, a complex reconstruction — is the genuine reason to fly, the opinion should name that element and no more.

The records that make a review possible

Cancer decisions are built on tissue and imaging. Before an oncologist can say anything useful about your case they want the full histopathology report, the imaging studies with their radiologist's reports, and where possible the pathology slides or block themselves, because a second reading of the original specimen is among the most valuable early steps a family can take. Add the letter from your oncologist naming the diagnosis, stage and proposed protocol, and a list of any cycles already completed. Reports in Russian or Uzbek are translated into English for the reviewing specialist, with the translation cost shown to you as its own line. From these records a reviewing oncologist can say whether the proposed protocol sits within accepted practice for your diagnosis, what it asks of you, and what should go back to your own team. Where the documents cannot support a view, the specialist will say so rather than improvise.

A protocol priced drug by drug

A cancer bill is a list, not a number: each systemic-therapy drug at its own dose and cycle, radiation priced per fraction, the surgery if there is one, repeat imaging, bed category, and the medicines you take home. Any quote that arrives as a single line has hidden all of that, and it is exactly where padded international quotes bury their margin. Every quote we obtain is itemized by the hospital itself, with each drug named and dosed on its own line, so that a mid-course change — a different drug, an extra scan, an unplanned admission — is a line you can see and question rather than a lump you must trust. You pay the hospital directly on its own invoice at rates locked in writing before you fly. We never hold treatment money, and our facilitation fee is published separately and never appears inside a hospital bill.

Funding documents a whole family can read

Most Uzbek cancer journeys are family-funded: parents, siblings, relatives earning in Russia, sometimes a wider circle — not an insurer. We build every document for that reality. The itemized quote, our separately invoiced fee and each milestone receipt are written to be forwarded into a Telegram or WhatsApp group and understood by people who did not attend the consultation, in a form that lets a family disagree, ask and decide together. What we will not do is invent funding: we publish country funding rails only where we have researched them, and for Uzbekistan's public arrangements around treatment abroad we have not — so this page names no scheme, quota or reimbursement figure that we cannot stand behind. If your employer or a private policy exists, put the question to them directly; what we control is paperwork that makes every som and dollar traceable.

Transplant paperwork, and the visa basics around it

Some of the largest Uzbek oncology cases are donor-based treatments — including certain bone-marrow transplants — and Indian law on living donors is strict: near-relative donors only, with the relationship file attested by your home authorities before departure and then routed through your embassy in India before a hospital authorisation committee will approve surgery. That chain adds weeks, and we map it at the start rather than after you land, telling you honestly if a file will not pass. The visa side itself is simpler: Uzbek citizens apply online for the e-Medical visa, companions for linked e-Medical Attendant visas, confirmed on the official portal when you apply. Tashkent–Delhi is a three-hour nonstop with many weekly departures as of mid-2026, plus a Mumbai–Tashkent service, and Tripcuro plans travel around the admission date your protocol actually requires, not around ticket prices.

What to prepare

• The complete histopathology report, and the pathology slides or tissue block if your laboratory will release them
• The actual imaging studies — CT, MRI and PET where they exist — carried as digital files or discs, together with the reports written about them
• The oncologist's letter from Tashkent naming the diagnosis, the stage and the protocol proposed
• A list of every treatment cycle already completed, with dates, plus your current medicine and dose list
• Laboratory results no older than a few weeks — blood counts plus kidney and liver function — because they bound what any protocol may include
• For any donor-based treatment: the donor's identity documents and your family-relationship paperwork, started early
• Passport validity and the name of the relative who will stay through the admission